Thymopoietin (TMPO) (Middle Region) Peptide
TMPO
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all Thymopoietin (TMPO) products
- Thymopoietin (TMPO)
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- QGTESRSSTP LPTISSSAEN TRQNGSNDSD RYSDNEEGKK KEHKKVKSTR
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TMPO Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Thymopoietin (TMPO)
- Background
-
The protein encoded by this gene resides in the nucleus and may play a role in the assembly of the nuclear lamina, and thus help maintain the structural organization of the nuclear envelope. It may function as a receptor for the attachment of lamin filaments to the inner nuclear membrane. Mutations in this gene are associated with dilated cardiomyopathy. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.
Alias Symbols: TP, LAP2, CMD1T, LEMD4, PRO0868
Protein Size: 694 - Gene ID
- 7112
- NCBI Accession
- NM_003276, NP_003267
- UniProt
- P42166
-
You are here:
